תוצאות חיפוש - F. Buonfiglioli
- Showing 1 - 4 results of 4
-
1
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals מאת Fabio Conti, F. Buonfiglioli, Alessandra Scuteri, Cristina Crespi, Luigi Bolondi, Paolo Caraceni, Francesco Giuseppe Foschi, Marco Lenzi, G. Mazzella, Gabriella Verucchi, Pietro Andreoné, S. Brillanti
יצא לאור 2016Artigo -
2
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals מאת Federico Ravaioli, Fabio Conti, S. Brillanti, Pietro Andreoné, G. Mazzella, F. Buonfiglioli, Ilaria Serio, G. Verrucchi, Maria Letizia Bacchi Reggiani, Agostino Colli, Giovanni Marasco, Antonio Colecchia, Davide Festi
יצא לאור 2018Artigo -
3
Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis מאת Andrea Lisotti, Francesco Azzaroli, F. Buonfiglioli, Marco Montagnani, Paolo Cecinato, Laura Turco, Claudio Calvanese, Patrizia Simoni, Massimo Guardigli, Rosario Arena, Alessandro Cucchetti, Antonio Colecchia, Davide Festi, Rita Golfieri, G. Mazzella
יצא לאור 2013Artigo -
4
Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older מאת Fabio Conti, S. Brillanti, F. Buonfiglioli, Ranka Vukotic, Maria Cristina Morelli, Claudine Lalanne, Marco Massari, Francesco Giuseppe Foschi, Veronica Bernabucci, Ilaria Serio, G.M. Prati, Eva Negri, Lorenzo Badia, Paolo Caraceni, Paolo Muratori, Giovanni Vitale, A Porro, Marta Morotti, G. Mazzella, Pietro Andreoné
יצא לאור 2016Artigo
כלי חיפוש:
נושאים קשורים
Cirrhosis
Gastroenterology
Internal medicine
Medicine
Hepatitis C
Hepatitis C virus
Hepatocellular carcinoma
Immunology
Multivariate analysis
Virus
Adverse effect
Environmental health
Esophageal varices
Hepatitis B virus
Indocyanine green
Liver cancer
Liver disease
Oncology
Pathology
Population
Portal hypertension
Proportional hazards model
Regimen
Ribavirin
Sofosbuvir
Tolerability
Univariate analysis